SPECIAL REPORT
The following summarizes some of the key data on biomarkers from the American Academy of Neurology annual meeting (AAN), San Diego, CA, April 5-9, 2025.
Neurofilament-light chain (NfL)
Combining sNfL and GFAP
Kappa free light chain
Read More
SPECIAL REPORT
The following summarizes some of the key data on ofatumumab from the American Academy of Neurology annual meeting (AAN), San Diego, CA, April 5-9, 2025.
Efficacy in early MS
First-line use of ofatumumab
Long-term efficacy and safety
Safety in pregnancy
Tuesday Edition
Monday Edition
The following summarizes some of the highlights from Day 3 of the American Academy of Neurology annual meeting (AAN), San Diego, CA, April 5-9, 2025.
MS risk with head trauma
Efficacy of first-line ofatumumab in patients without highly active disease
Semaglutide may reduce MS progression
Higher MS risk with earlier menarche
Biomarker dynamics after DMT initiation
Clinical tip of the day
Wednesday Edition
Monday Edition
The following summarizes some of the highlights from Day 2 of the American Academy of Neurology annual meeting (AAN), San Diego, CA, April 5-9, 2025.
Ofatumumab long-term data
KFLC a long-term predictor of disability worsening
BAFF a potential predictor of low Ig
Tolebrutinib in SPMS
Clinical tip of the day